Disclosure Panels Details Page
Soft Tissue Sarcoma Panel - Disclosures as of 09/23/2014
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Robert Benjamin MD | Immune Design Johnson & Johnson |
None | None | None | ✔ |
| Mary Anne Bergman | None | None | None | None | ✔ |
| Sarah Boles MD | None | None | None | None | ✔ |
| Marilyn Bui MD, PhD | None | None | None | None | ✔ |
| Ernest Conrad III MD | None | None | None | None | - |
| Jose Costa MD, FACP | NA | NA | NA | NA | - |
| Thomas DeLaney MD | None | Chordoma Foundation | Evidence for Healthcare Improvement Group H Monitor Deloitte Consulting The Planning Shop |
GSK | ✔ |
| Fayna Ferkle PharmD | None | None | None | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| Kristen Ganjoo MD | None | None | EMD Serono/Advisory Board | None | ✔ |
| Suzanne George MD | ARIAD Pharmaceuticals, Inc. Bayer HealthCare GSK Novartis Pharmaceuticals Corporation Pfizer Inc. |
ARIAD Pharmaceuticals, Inc. Blueprint Medicines Novartis Pharmaceuticals Corporation |
None | None | - |
| Ricardo Gonzalez MD | None | None | Novartis Pharmaceuticals Corporation | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Martin Heslin MD | None | None | None | None | - |
| John Kane III MD | None | None | None | None | ✔ |
| Joel Mayerson MD | Millennium Pharmaceuticals, Inc. | None | None | None | - |
| Martin McCarter MD | None | None | None | None | - |
| Joan McClure MS | None | None | None | None | ✔ |
| Sean McGarry MD | None | Musculoskeletal Transplant Foundation | None | Musculoskeletal Transplant Foundation | ✔ |
| Christian Meyer MD, PhD | None | None | None | None | - |
| Richard O`Donnell MD | None | None | None | None | - |
| Alberto Pappo MD | None | None | Ziopharm |
None | - |
| I. Benjamin Paz MD | None | None | Genomic Health, Inc. | None | ✔ |
| Ivy Petersen MD | NA | NA | NA | NA | - |
| John Pfeifer MD, PhD | None | Agilent Novartis Pharmaceuticals Corporation Strand Analytical Labs |
None | PierianDX, an NGS software vendor that currently has no cash value | ✔ |
| R. Lor Randall MD, FACS | Children`s Oncology Group Connective tissue Oncology Society Musculoskeletal Tumor Society |
Biomet, Inc. Musculoskeletal Transplant Foundation Sarcoma Foundation of America |
Biomet, Inc. Musculoskeletal Transplant Foundation |
None | ✔ |
| Richard Riedel MD | Astex Pharmaceuticals CytRx Corporation Eisai Inc. GSK Infinity Pharmaceuticals Millennium Pharmaceuticals, Inc. Morphotek Inc. Novartis Pharmaceuticals Corporation Threshold Tracon Ziopharm |
CytRx EMD Serono Morphotek Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Jillian Scavone PhD | None | None | None | None | ✔ |
| Scott Schuetze MD, PhD | AB Sciences Amgen Inc. CytRx Johnson & Johnson SARC Threshold |
None | None | None | ✔ |
| Karen Schupak MD | None | None | None | None | - |
| Herbert Schwartz MD | None | None | Musculoskeletal Transplant Foundation | Musculoskeletal Transplant Foundation | - |
| William Tap MD | ImClone Systems Incorporated Morphotek Inc. Threshold Pharmaceuticals |
Novartis Pharmaceuticals Corporation Plexxikon Pharmaceuticals |
None | None | ✔ |
| Margaret Von Mehren MD | Arog Pharmaceuticals Astex Pharmaceuticals Eisai Inc. Johnson & Johnson Merck & Co., Inc. Morphotek Inc. National Cancer Institute Novartis Pharmaceuticals Corporation OSI Pharmaceuticals, Inc. Pfizer Inc. Sarcoma Alliance for Research through Collaboration Synta Pharmaceuticals Corp. |
Eisai Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Jeffrey Wayne MD | None | Novartis Pharmaceuticals Corporation | Novartis Pharmaceuticals Corporation | None | - |